Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Specific PHGKB|Primary Immune Deficiency PHGKB|PHGKB

Last Posted: May 17, 2022
news Latest News and Publications
Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins. External Web Site Icon
Eguía Jorge, et al. Immunology 2022 0 0.
Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy. External Web Site Icon
Antolí Arnau, et al. Frontiers in immunology 2022 0 0. 895209
Common Variable Immunodeficiency Associated with a De Novo IKZF1 Variant and a Low Humoral Immune Response to the SARS-CoV-2 Vaccine. External Web Site Icon
Díaz-Alberola Irene, et al. Journal of clinical medicine 2022 0 0. (9)
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine. External Web Site Icon
Boulouis Caroline, et al. Molecular medicine (Cambridge, Mass.) 2022 0 0. (1) 54
Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib. External Web Site Icon
Pararajasingam Abirami, et al. Frontiers in pediatrics 2022 0 0. 837568
T-cell responses to SARS-CoV-2 in healthy controls and primary immunodeficiency patients. External Web Site Icon
Awuah Arnold, et al. Clinical and experimental immunology 2022 0 0. (3) 336-339
Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant. External Web Site Icon
Lindahl Hannes, et al. Journal of clinical immunology 2022 0 0.
Acute Eosinophilic Pneumonia Following mRNA COVID-19 Vaccination: A Case Report. External Web Site Icon
Barrio Piqueras Miguel, et al. Archivos de bronconeumologia 2021 0 0. 53-54
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases. External Web Site Icon
Bourguiba Rim, et al. RMD open 2022 0 0. (1)
Eosinophilic Pneumonia Associated to SARS-CoV-2 Vaccine. External Web Site Icon
Costa E Silva Margarida, et al. Archivos de bronconeumologia 2021 0 0. 51-52


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.